Search - tctmd.com

Displaying 221 - 240 of 484

Sort: Relevancy | Date

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane

October 12, 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara

October 12, 2015

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Presentation TCT 2015

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

How Did I Treat a Patient With Distal a Left Main Bifurcation and Intermediate Syntax Score?

Presentation TCT 2015

How Did I Treat a Patient With Distal a Left Main Bifurcation and Intermediate Syntax Score?

Presenter: Run-Lin Gao, Gregg W. Stone, Bo Xu, Zening Jin

October 11, 2015

How Would I Treat a Patient With a Distal Left Main Bifurcation and Intermediate Syntax Score?

Presentation TCT 2015

How Would I Treat a Patient With a Distal Left Main Bifurcation and Intermediate Syntax Score?

Presenter: Run-Lin Gao, Gregg W. Stone, Bo Xu, Jian Liu

October 11, 2015

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Presentation TCT 2015

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Presentation TCT 2015

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Presenter: Kevin J. Beatt, Craig R. Smith, Philippe Généreux

October 11, 2015

From SYNTAX to EXCEL: What Answers Can We Expect (and Not Expect) From EXCEL?

Presentation TCT 2015

From SYNTAX to EXCEL: What Answers Can We Expect (and Not Expect) From EXCEL?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Patrick W. Serruys

October 11, 2015

News Opinion Fellow Talk

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

October 11, 2015

News Conference News TCT 2015

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

October 11, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

介入心脏病学 ABIM 认证与 PCI 结局的相关性不强

October 01, 2015

News Daily News

La Certificación ABIM en Cardiología Intervencionista No Tuvo Mucho que Ver con los Resultados PCI

October 01, 2015

News Daily News

Interventional Cardiology ABIM Certification Not Strongly Linked to PCI Outcomes

October 01, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

News Daily News

研究表明对多支血管CAD采取多支动脉CABG有益

September 24, 2015

News Daily News

Un Estudio Avala la CABG Multiarterial para el Manejo de la EAC Multivaso

September 24, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

September 24, 2015

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

August 12, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.